Clinical Trials Database
🇨🇳 China

🇨🇳 China Clinical Trials Database

Search 109,000+ clinical trials conducted in China. Access comprehensive trial data including phases, sponsors, outcomes, and locations from Chinese Clinical Trial Registry (ChiCTR). Part of Pure Global AI's free database with 840,000+ trials worldwide.

Free Database
Powered by Pure Global AI
109,000+ Trials
Search China Clinical Trials
Search 109,000+ clinical trials in China. Enter disease, drug name, sponsor, or trial ID...
Popular searches:
DJ Fang
DJ Fang
MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Frequently Asked Questions
Common questions about the China clinical trials database

What is the China clinical trials database?

The China clinical trials database contains over 109,000 clinical trials registered through ChiCTR (Chinese Clinical Trial Registry) and international registries. China has the world's second-largest pharmaceutical market.

How do I search for clinical trials in China?

Enter a disease name, drug name, sponsor, or trial ID in the search box. You can search in English or Chinese.

What regulatory body oversees clinical trials in China?

NMPA (National Medical Products Administration) oversees clinical trials in China. The Center for Drug Evaluation (CDE) reviews trial applications.

Is this database free to use?

Yes, this database is completely free. Pure Global AI provides free access to help researchers and companies navigate Chinese clinical research.

What types of trials are common in China?

China has significant trials in oncology, hepatitis, cardiovascular disease, and traditional Chinese medicine. Many global trials now include Chinese sites.

How has China's clinical trial landscape changed?

China has dramatically reformed its clinical trial regulations since 2017, reducing approval times and accepting international multi-regional clinical trial (MRCT) data. This has increased global pharma investment in Chinese clinical development.

About This Database

This database provides free access to clinical trial data from China. China is the world's second-largest pharmaceutical market with 1.4 billion people. Recent regulatory reforms have made China more attractive for global clinical development programs.